Outcome and prognostic factors of children with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib followed by allogeneic hematopoietic cell transplantation in first remission

BACKGROUND: Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is a subset of ALL with poor prognosis. Here, we analyzed the outcomes and prognostic factors of children with Ph+ ALL who received imatinib and chemotherapy followed by allogeneic hematopoietic cell transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Juae, Lee, Na Yeong, Kim, Seongkoo, Lee, Jae Wook, Jang, Pil-Sang, Chung, Nack-Gyun, Cho, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439289/
https://www.ncbi.nlm.nih.gov/pubmed/30956963
http://dx.doi.org/10.5045/br.2019.54.1.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439289/
https://www.ncbi.nlm.nih.gov/pubmed/30956963
http://dx.doi.org/10.5045/br.2019.54.1.45

Ejemplares similares